兰卫医学 (301060.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(兰卫医学)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度每股收益(元) -----1.00-
 单季度销售毛利率(%) 22.0022.0029.0039.0038.0046.0048.00
 单季度销售净利率(%) 2.00-8.004.001.0020.0024.0028.00
 单季度净资产收益率ROE(%) --1.001.001.009.0014.0011.00
 单季度总资产净利率ROA(%) --1.00--6.0011.0010.00
单季度财务摘要:
 单季度营业总收入(元) 431,965,957.00425,322,272.00412,587,989.001,090,478,595.001,048,169,276.001,232,967,453.00827,689,742.00
 单季度营业总成本(元) 420,954,958.00412,261,060.00368,985,557.00883,566,608.00774,103,542.00864,661,427.00548,725,859.00
 单季度营业收入(元) 431,965,957.00425,322,272.00412,587,989.001,090,478,595.001,048,169,276.001,232,967,453.00827,689,742.00
 单季度营业利润(元) 11,801,942.00-28,672,546.0022,542,612.0056,544,492.00258,645,923.00354,359,368.00279,726,067.00
 单季度利润总额(元) 11,643,489.00-30,757,291.0019,627,655.0024,360,558.00251,746,972.00351,681,094.00276,654,778.00
 单季度净利润(元) 8,429,228.00-33,387,429.0015,591,015.006,131,573.00206,214,133.00295,552,113.00231,157,344.00
 单季度归属母公司股东的净利润(元) 942,556.00-23,235,712.0021,413,081.0013,004,004.00173,770,428.00253,309,165.00177,239,160.00
 单季度经营活动产生的现金流量(元) 117,313,394.0076,851,363.0061,732,451.00329,095,469.0027,194,685.00-119,977,075.00-152,146,040.00
 单季度投资活动产生的现金流量(元) -419,968,589.00-18,913,251.00-16,733,022.00-43,598,375.00-87,640,583.00263,290,914.0048,001,364.00
 单季度筹资活动产生的现金流量(元) 102,528,816.00-23,819,493.0011,309,553.0049,471,611.0019,889,100.00-15,559,061.00-3,316,868.00
 单季度现金及现金等价物净增加(元) -200,261,866.0034,075,965.0056,341,199.00334,867,523.00-40,820,631.00127,580,481.00-107,478,726.00

前瞻产业研究院